• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour .

作者信息

Mathian Alexis, Amoura Zahir

机构信息

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

出版信息

Ann Rheum Dis. 2021 Mar;80(3):e34. doi: 10.1136/annrheumdis-2020-217875. Epub 2020 May 29.

DOI:10.1136/annrheumdis-2020-217875
PMID:32471900
Abstract
摘要

相似文献

1
Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour .对Nikpour所著《17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程》的回复
Ann Rheum Dis. 2021 Mar;80(3):e34. doi: 10.1136/annrheumdis-2020-217875. Epub 2020 May 29.
2
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.关于“17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程”的通信
Ann Rheum Dis. 2021 Mar;80(3):e33. doi: 10.1136/annrheumdis-2020-217827. Epub 2020 May 29.
3
Response to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian ' by Notz .回复：“抗风湿药物、B细胞耗竭与重症COVID-19：关于Mathian等人‘17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程’的通信” 作者：诺茨
Ann Rheum Dis. 2022 Nov;81(11):e217. doi: 10.1136/annrheumdis-2020-218795. Epub 2020 Nov 25.
4
Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian .
Ann Rheum Dis. 2022 Nov;81(11):e216. doi: 10.1136/annrheumdis-2020-218778. Epub 2020 Aug 28.
5
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.关于“17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程”的通信
Ann Rheum Dis. 2023 Nov;82(11):e225. doi: 10.1136/annrheumdis-2021-220410. Epub 2021 Apr 21.
6
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.关于“17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程”的通信
Ann Rheum Dis. 2023 Oct;82(10):e215. doi: 10.1136/annrheumdis-2020-219648. Epub 2021 Jan 15.
7
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病（COVID-19）临床病程
Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24.
8
Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon .对卡里永所著《长期接受羟氯喹治疗的系统性红斑狼疮患者的COVID-19临床病程》的回应
Ann Rheum Dis. 2021 Apr;80(4):e55. doi: 10.1136/annrheumdis-2020-217990. Epub 2020 May 31.
9
Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.长期接受羟氯喹治疗的系统性红斑狼疮患者的新型冠状病毒肺炎临床病程
Ann Rheum Dis. 2021 Apr;80(4):e54. doi: 10.1136/annrheumdis-2020-217847. Epub 2020 May 31.
10
Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.氯喹和羟氯喹治疗新冠病毒疾病的潜力引发了系统性红斑狼疮患者对药物短缺的担忧。
Nat Med. 2020 May;26(5):632. doi: 10.1038/s41591-020-0853-0.